Composition for treating a pulmonary hypertension

Details Composition for treating a pulmonary hypertension Composition for treating a pulmonary hypertension

A - Human Necessities

61

K

A61K 31/505 (2006.01) A61P 9/12 (2006.01) C07D 239/04 (2006.01)

Patent

CA 2669536

A method for treating a pulmonary hypertension condition such as pulmonary arterial hypertension (PAH) in a subject comprises administering to the subject a therapeutically effective amount of ambrisentan, wherein, at baseline, time from first diagnosis of the condition in the subject is not greater than about 2 years.

Procédé permettant de traiter l'hypertension pulmonaire, notamment l'hypertension artérielle pulmonaire (HAP) chez un sujet. Ledit procédé comprend l'administration chez le sujet d'une quantité thérapeutiquement efficace d'ambrisentan. A la base, le premier diagnostic de la pathologie chez le sujet ne date pas de plus d'environ 2 ans.

Affiliated with

Also associated with

Rating

Composition for treating a pulmonary hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for treating a pulmonary hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for treating a pulmonary hypertension will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2076707